Systolic Pressure Index in Assessing the Risk of Cardiovascular Events (IPS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00925964|
Recruitment Status : Completed
First Posted : June 23, 2009
Last Update Posted : March 15, 2012
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||504 participants|
|Official Title:||Interest of Measuring the Systolic Pressure Index in Assessing the Risk of Cardiovascular Events Peri-operatively in the Surgery, Settled Out of Cardiovascular Surgery|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||August 2009|
|Actual Study Completion Date :||September 2009|
Patients with Systolic Pressure Index <0,9 ou >1,4.
Patients not exposed
Patients with Systolic Pressure Index >0,9 ou <1,4.
- It is a composite involving the following events: death, cardiovascular death, acute coronary syndrome, left cardiac decompensation, stroke, transient ischemic attack [ Time Frame: day1, day 2, day 3, 1 month, 1 year ]
- - for the short term increase in the length of hospitalization - for the long term: death, cardiovascular death, hospitalization for acute coronary syndrome, cardiac decompensation left, TIA, stroke, acute ischemia and ischemia critical member. [ Time Frame: day1, day 2, day 3, 1 month, 1 year ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00925964
|Explorations fonctionnelles vasculaires et angiologie (Hôpital Dupuytren)|
|Limoges, France, 87000|
|Principal Investigator:||Philippe LACROIX, MD||University Hospital, Limoges|